Haemo Pharma
Haemo Pharma is an Austrian family-owned company founded in 2006, dedicated to supporting medical professionals with innovative, evidence-based products in regenerative medicine, orthopedics, and related fields. They focus on long-term joint maintenance, high product quality, and reliable support for hospitals, clinics, pharmacies, and sports medicine. The company actively participates in conferences, symposia, and sports sponsorships to promote joint health and regenerative therapies.
Industries
Nr. of Employees
small (1-50)
Haemo Pharma
Products
Autologous cartilage spheroid cell therapy
Personalized autologous cartilage cell therapy produced from patient cells, expanded and formed into spheroids for implantation to repair focal cartilage defects.
Hyaluronic acid viscosupplements (single-injection formulations)
Intra-articular hyaluronic acid formulations intended for pain relief and functional improvement in osteoarthritis; some single-injection options combine HA with a short-acting corticosteroid.
Hyaluronic acid scaffold for cartilage regeneration
Three-dimensional hyaluronic acid scaffold intended as a matrix to support cartilage repair and integration in surgical cartilage repair procedures.
Point-of-care stem cell isolation systems and kits
Centrifugation-based devices and consumable kits for isolation and concentration of stem cells and bone marrow aspirate for immediate use in regenerative procedures.
Autologous blood-derived therapy kits (PRP / APC / ACS)
Platforms and kits for preparation of platelet-rich plasma, autologous platelet concentrates and autologous conditioned serum for regenerative treatments.
Nanofracture and cartilage debridement instruments
Instruments and technique adjuncts to perform precise cartilage debridement and nanofracture to stimulate biological cartilage repair.
Autologous cartilage spheroid cell therapy
Personalized autologous cartilage cell therapy produced from patient cells, expanded and formed into spheroids for implantation to repair focal cartilage defects.
Hyaluronic acid viscosupplements (single-injection formulations)
Intra-articular hyaluronic acid formulations intended for pain relief and functional improvement in osteoarthritis; some single-injection options combine HA with a short-acting corticosteroid.
Hyaluronic acid scaffold for cartilage regeneration
Three-dimensional hyaluronic acid scaffold intended as a matrix to support cartilage repair and integration in surgical cartilage repair procedures.
Point-of-care stem cell isolation systems and kits
Centrifugation-based devices and consumable kits for isolation and concentration of stem cells and bone marrow aspirate for immediate use in regenerative procedures.
Autologous blood-derived therapy kits (PRP / APC / ACS)
Platforms and kits for preparation of platelet-rich plasma, autologous platelet concentrates and autologous conditioned serum for regenerative treatments.
Nanofracture and cartilage debridement instruments
Instruments and technique adjuncts to perform precise cartilage debridement and nanofracture to stimulate biological cartilage repair.
Services
Controlled-temperature warehousing and transport for sensitive medical products and pharmaceuticals with continuous monitoring and regulatory-compliant handling.
Installation, setup, routine maintenance, calibration and rapid technical troubleshooting for supplied medical and therapeutic devices, provided on-site or remotely.
On-site support during clinical procedures to optimize product use, provide customization, and resolve issues in real time.
Targeted therapies, preventive programs and individualized rehabilitation support for professional and amateur athletes to accelerate recovery and reduce injury risk.
Structured educational programs for clinicians and therapists covering indications, device use, surgical techniques and clinical protocols, including hands-on practice and anatomical preparation sessions.
Design and delivery of focused symposia and conference sessions to present clinical data, new techniques and product-related evidence to specialist audiences.
Controlled-temperature warehousing and transport for sensitive medical products and pharmaceuticals with continuous monitoring and regulatory-compliant handling.
Installation, setup, routine maintenance, calibration and rapid technical troubleshooting for supplied medical and therapeutic devices, provided on-site or remotely.
On-site support during clinical procedures to optimize product use, provide customization, and resolve issues in real time.
Targeted therapies, preventive programs and individualized rehabilitation support for professional and amateur athletes to accelerate recovery and reduce injury risk.
Structured educational programs for clinicians and therapists covering indications, device use, surgical techniques and clinical protocols, including hands-on practice and anatomical preparation sessions.
Design and delivery of focused symposia and conference sessions to present clinical data, new techniques and product-related evidence to specialist audiences.
Expertise Areas
- Regenerative medicine
- Cartilage repair and autologous cartilage cell therapies
- Viscosupplementation and scaffold-based cartilage regeneration
- Autologous blood- and cell-derived therapies (PRP, ACS, platelet concentrates, bone marrow concentrates)
Key Technologies
- Autologous spheroid cell therapy
- Hyaluronic acid-based scaffolds
- Point-of-care centrifugation for cell isolation
- Automated autologous blood/cell processing platforms
News & Updates
Haemo Pharma supported the ATP tennis tournament in Kitzbühel with modern therapy devices for quick regeneration.
Event held in Frankfurt on June 5, 2025, focusing on cartilage therapy and bio-skills training.
A successful foundational course on cartilage specialists, highlighting current developments in cartilage therapy.
Hyalofast® has received MDR approval, setting new standards in cartilage regeneration.
The premiere of the Knee+Ski Congress took place in Fieberbrunn from February 19 to 23, 2025.
A recent long-term study (Whyte et al. 2024) confirms the sustainable effectiveness of HyaloFast.
Haemo Pharma supported the ATP tennis tournament in Kitzbühel with modern therapy devices for quick regeneration.
Event held in Frankfurt on June 5, 2025, focusing on cartilage therapy and bio-skills training.
A successful foundational course on cartilage specialists, highlighting current developments in cartilage therapy.
Hyalofast® has received MDR approval, setting new standards in cartilage regeneration.
The premiere of the Knee+Ski Congress took place in Fieberbrunn from February 19 to 23, 2025.
A recent long-term study (Whyte et al. 2024) confirms the sustainable effectiveness of HyaloFast.